Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

Are you aware that molecular testing is necessary to inform the appropriate adjuvant treatment decision for patients? Credit available for this activity expires: 3/22/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000409?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Mar 26, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

0:00 37:50

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 37 minutes long.

When was this Keeping Current CME episode published?

This episode was published on March 26, 2024.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!